Abstract

Clinical methods for assessing the severity of the condition in epidermolysis bullosa are the most accessible means at the first stage of diagnosis, help to establish a clinical diagnosis, substantiate the need of consultations of specialists, and optimize the subsequent routing of the patient. In addition, the availability of tools helps to validate data, consistently assess the severity of the disease and record the therapeutic response in randomized trials of new pathogenetic treatments.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call